Tech Transfer At A Glance For Startups
Most startups request an exclusive license because they believe it is required to raise funding for the company. YALE STARTUP LICENSE. Yale strongly encourages innovators with non-therapeutic discoveries looking to start companies to take advantage of our pre-negotiated Startup License. The Startup License is based on transparency and fairness, offering the exact same, very favorable terms to all Yale startups. Further, by reducing all uncertainty as to the terms of the license, startups can comfortably take an option to license the technology, thus deferring the need to sign the license until such time that they feel ready to assume the responsibilities of a licensee.
While Yale’s primary mission in licensing technology to startups is to promote the development of products or services that benefit society based upon Yale research, Yale does seek a reasonable financial return from its licensees so that it can reinvest in its education and research missions. STARTUP LICENSE PROCESS. For Yale entrepreneurs demonstrating a diligent effort to start a company based on Yale technology that includes one or more Principal Investigators as founders of the company, the process of getting a Startup license is very simple. Entrepreneurs may then execute the Startup License immediately, or, if still in the formative stage, extend their option as they seek to raise financing or other sources of cash that will allow them to make the payments required once the license is executed. Benefits to Startups and to Yale Community: Reduces the time and legal expense to get a license done, freeing time and resources to focus on developing business.
Offers predictable, consistent, and fair license terms to all startups. YALE THERAPEUTICS LICENSES. Therapeutic startups are not eligible for the Yale Startup License. NIH-funded research in the biosciences represents the bulk of funded research at Yale, and as a consequence, almost all of the most significant startups with licenses from Yale are for drug discovery technologies and/or for therapeutic agents themselves. Rather than view large companies as lesser-preferred alternatives to a startup, many of our startups have been launched with the participation of pharmaceutical companies, either with license to a very limited field, research collaboration or sponsorship, and/or investment from their corporate venture group.
34 New Indian Tech Startup Funds Launched In 2017
After the 2016 funding winter, the year 2017 witnessed a lot of course-correction in all sectors, thereby building the investor’s trust over the Indian startups again. As a result, over 34 new tech startup funds were launched in 2017, raking in over $2.3 Bn funds, reveals Inc42’s Annual Indian Tech Startup Funding Report 2017. The report also highlights the active contribution of the Indian corporate sector in setting up new startup funds. Of the 34 newly launched funds, 21 funds were launched by corporates while six funds were led by the Indian government or government bodies. Besides these new funds, over 14 existing startup funds raised a new fund for India investments or disclosed plans of raising a new fund with a combined corpus of $986 Mn.
Also, the report identifies 10 new startup funds which are yet to be launched to invest in the Indian tech startup ecosystem, including the likes of VC Fund Vedanta Group Founder, Sandeep Aggarwal Family Fund, The Fundamentum Partnership, HDFC Bank Startup Fund, Xiaomi Startup Fund and more. Interestingly, of the upcoming tech startup funds, five are corporate funds. Alteria Capital: The co-founders of Mumbai-based venture debt fund InnoVen Capital Ajay Hattangdi and Vinod Murali launched Alteria Capital, a debt fund with a corpus of about $157 Mn. The Category II investment fund, will have a tenure of seven, with a possible extension of two years. The fund is looking to make the first close of the fund by the first quarter of 2018.
Alteria Capital will have an average ticket size from $471K – $15.7 Mn. Unitary Helion: Rahul Chandra, MD, Helion Venture Partners announced to float $100 Mn worth Unitary Helion tech fund in May 2017 and raised the first corpus in October 2017. Epiq Capital India Fund: Mumbai-based PE firm Epiq Capital announced the first close of its $200 Mn-$250 Mn maiden tech startup fund in November 2017. Stellaris Venture Partners: An early-stage startup focussed fund, Stellaris Venture invests in global SaaS, applications for Indian small and mid-sized business and consumers in large verticals such as healthcare, education, financial services, and retail. Trend Micro Startup Fund: Trend Micro launched a $100 Mn corporate venture fund in June 2017 with an aim to nurture a portfolio of startups in emerging ecosystems such as the Internet of Things.
START-UP NY :: University of Rochester
As one of the nation’s leading research institutions the University of Rochester has brought education, research, and commercialization together to become a major hub of innovation and economic growth. The University of Rochester STARTUP-NY Plan has designated 105,894 square feet of space at High Tech Rochester’s Lennox Tech Enterprise Center and at two buildings within Eastman Business Park. Governor Cuomo’s groundbreaking START-UP NY initiative will give approved companies tax exemptions for 10 years, when they locate on designated areas associated with colleges and universities and align with a school’s core academic mission. The University of Rochester’s START-UP NY plan is focused on attracting eligible companies in the broad fields of science, engineering, social science, health science, business, and music. Research: Companies commercializing University of Rochester research or with technology interests that align with University programs and can be further developed through collaborations.
Training, experiential learning or mentoring: Learning opportunities for students and trainees can be facilitated between companies and University of Rochester programs or centers. Access to facilities/research infrastructure: Companies may have use for some of the shared research facilities and centers at the University of Rochester. Applications will be evaluated for factors including: economic and community benefit, business model, technology cluster and alignment with specific University domains of excellence and mission. Businesses interested in partnering with the University of Rochester should initially contact Adam Tulgan at adam. Applications reaching the second stage of review will be evaluated more comprehensively for factors including: economic and community benefit, business model, technology cluster and alignment with specific University domains of excellence and mission.
The evaluations will be conducted by a Review Committee comprised of representatives the University of Rochester, High Tech Rochester, Excell Partners, Eastman Business Park, and the community leaders. The University of Rochester STARTUP-NY plan designates 105,894 sq.